Dr. Rene Cabeza, MD
What this data tells you about Dr. Cabeza
Dr. Rene Cabeza is an optician in Orange City, FL, with 19 years in practice. Based on federal Medicare data, Dr. Cabeza performed 131,948 Medicare services across 6,568 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cabeza received a total of $12,810 from 12 pharmaceutical and/or device companies across 22 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cabeza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 61,219 | $0 | $2 |
| Iron sucrose injection (Venofer) | 32,401 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 10,202 | $43 | $120 |
| Denosumab injection (Prolia/Xgeva) | 5,820 | $19 | $43 |
| Contrast dye for imaging (iodine-based) | 3,200 | $0 | $0 |
| Dexamethasone injection (steroid) | 2,110 | $0 | $1 |
| Complete blood count (CBC) with differential | 1,649 | $8 | $18 |
| Blood draw (venipuncture) | 1,503 | $4 | $4 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,413 | $1 | $12 |
| Comprehensive metabolic blood panel | 1,178 | $10 | $29 |
| Phosphate level test | 1,091 | $5 | $15 |
| Drug injection, under skin or into muscle | 861 | $10 | $76 |
| Vitamin B-12 level test | 821 | $15 | $43 |
| Folic acid level test | 820 | $14 | $42 |
| Ferritin level test (iron stores) | 800 | $13 | $39 |
| Iron level test | 794 | $6 | $18 |
| Iron binding capacity test | 793 | $9 | $24 |
| Office visit, established patient (20-29 min) | 722 | $64 | $219 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 610 | $1 | $5 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 530 | $21 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 341 | $46 | $117 |
| Administration of chemotherapy into vein, 1 hour or less | 339 | $96 | $415 |
| Office visit, established patient (30-39 min) | 280 | $96 | $321 |
| Injection of additional new drug or substance into vein | 186 | $12 | $41 |
| Injection, diphenhydramine hcl, up to 50 mg | 171 | $1 | $2 |
| Administration of chemotherapy into vein, each additional hour | 160 | $21 | $90 |
| Lactate dehydrogenase (enzyme) level | 143 | $6 | $16 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 124 | $15 | $60 |
| Hospital follow-up visit, moderate complexity | 124 | $63 | $213 |
| Carcinoembryonic antigen (cea) protein level | 117 | $19 | $49 |
| Administration of additional new drug or substance into vein, 1 hour or less | 113 | $48 | $160 |
| Initial hospital admission, high complexity | 110 | $137 | $605 |
| Prothrombin time test (blood clotting) | 108 | $4 | $15 |
| Office visit, established patient (10-19 min) | 107 | $39 | $131 |
| Injection of drug or substance into vein | 97 | $28 | $92 |
| Infusion into a vein for hydration, each additional hour | 93 | $10 | $30 |
| Thyroid stimulating hormone (TSH) test | 59 | $16 | $57 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 56 | $1 | $3 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 54 | $20 | $58 |
| Hospital follow-up visit, high complexity | 50 | $91 | $307 |
| Cystatin c (enzyme inhibitor) level | 49 | $18 | $37 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 46 | $402 | $560 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 45 | $1,107 | $3,475 |
| New patient office visit (30-44 min) | 44 | $82 | $327 |
| Magnesium level test | 43 | $7 | $18 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 38 | $51 | $123 |
| Office visit, established patient, complex (40-54 min) | 38 | $136 | $430 |
| Infusion, normal saline solution , 1000 cc | 38 | $2 | $6 |
| PSA test (prostate cancer screening) | 34 | $18 | $52 |
| Infusion into a vein for hydration, 31-60 minutes | 34 | $24 | $97 |
| New patient office visit (45-59 min) | 33 | $127 | $500 |
| Hospital follow-up visit, low complexity | 32 | $40 | $116 |
| Ct scan of chest with contrast | 30 | $86 | $979 |
| CT scan of abdomen and pelvis with contrast | 25 | $174 | $987 |
| Irrigation of implanted venous access drug delivery device | 23 | $18 | $55 |
| New patient office visit, complex (60-74 min) | 14 | $173 | $618 |
| CT scan of chest, without contrast | 13 | $69 | $597 |
Industry Payment Transparency
Open Payments through 2022 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2022)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2022 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cabeza is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 11%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cabeza experienced with iron infusion (feraheme)?
Does Dr. Cabeza receive payments from pharmaceutical companies?
How do Dr. Cabeza's costs compare to other opticians in Orange City?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology